Worth around $3.0 billion in 2018 and projected to reach $10.0 billion by 2025, the global bioprotection market was showing an annual growth rate of 15-18% before the COVID pandemic.
Underlying this growth were numerous factors that have only recently started to be recognised and discussed, such as an urgent need to “fill the gaps” in the market due to removal of synthetic pesticides.
However, the COVID pandemic affected all areas of scientific research. Biopesticide developers have been impacted by restrictions on practical research and funding, which have only added to pre-existing obstacles of regulatory hurdles, commercial uptake and formulation challenges. On the other hand, COVID apparently led to surging consumer demand for organic produce with no chemical residues and, in the wake of Brexit, the UK government has declared a commitment to support science and technology, and an intention to expand partnerships across the globe.
The WBF engages with top-class academics and researchers, linking them with the biocontrol industry to facilitate innovation and commercialisation. We also undertake the task of leading a dialogue with the UK government, to drive reform in matters most important to our members. For example, industry collaboration can help educational institutes to resolve IP issues. The WBF actively encourages key regulators, policy makers, investors, environmentalists, and government organisations globally to work together.
Our mission is to bridge the gap between academia and industry globally, and to ensure the successful development and commercialisation of biocontrol products, by helping our members to overcome challenges and leverage opportunities in a post-COVID, post-Brexit new world order.